Serotonin plays a recognized role in both pulmonary hypertension and depression: signaling through receptors such as 5-HT1B promotes vascular remodeling in PAH (69), while changes in serotonin binding and metabolism are linked to mood disturbances in MDD (70). This evidence concerns the gene HTR1B and pulmonary hypertension.